image_alt_text
1

Maria-Teresa Peracchia, Ph.D.

AIMBE College of Fellows Class of 2020
For outstanding contributions for development, approval and commercialization of Dupixent, from the strategic alliance between Sanofi and Regeneron.

Dr. Maria-Teresa Peracchia Inducted into AIMBE College of Fellows

Via AIMBE | March 30, 2020

WASHINGTON, D.C. — The American Institute for Medical and Biological Engineering (AIMBE) has announced the induction of Maria-Teresa Peracchia, Ph.D., Global Head, Drug Delivery and Product Integration, Biologics Drug Product Development, Sanofi R&D, to its College of Fellows.

Election to the AIMBE College of Fellows is among the highest professional distinctions accorded to a medical and biological engineer. The College of Fellows is comprised of the top two percent of medical and biological engineers. College membership honors those who have made outstanding contributions to “engineering and medicine research, practice, or education” and to “the pioneering of new and developing fields of technology, making major advancements in traditional fields of medical and biological engineering, or developing/implementing innovative approaches to bioengineering education.”

Dr. Peracchia was nominated, reviewed, and elected by peers and members of the College of Fellows for “outstanding contributions for development, approval and commercialization of Dupixent, from the strategic alliance between Sanofi and Regeneron.

...